期刊
IMMUNITY
卷 44, 期 4, 页码 913-923出版社
CELL PRESS
DOI: 10.1016/j.immuni.2016.04.003
关键词
-
类别
资金
- V Foundation Translational Research Grant
- National Cancer Institute of the NIH [P30CA033572]
- [R01CA122976]
- [R01CA146092]
- [P50 CA107399]
The participation of a specific subset of B cells and how they are regulated in cancer is unclear. Here, we demonstrate that the proportion of CD5(+) relative to interleukin-6 receptor alpha (IL-6R alpha)-expressing B cells was greatly increased in tumors. CD5(+) B cells responded to IL-6 in the absence of IL-6R alpha. IL-6 directly bound to CD5, leading to activation of the transcription factor STAT3 via gp130 and its downstream kinase JAK2. STAT3 upregulated CD5 expression, thereby forming a feed-forward loop in the B cells. In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. CD5(+) B cells also showed activation of STAT3 in multiple types of human tumor tissues. Thus, our findings demonstrate a critical role of CD5(+) B cells in promoting cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据